Related references
Note: Only part of the references are listed.Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis
Jifang Zhou et al.
JOURNAL OF CANCER SURVIVORSHIP (2020)
Real-world impact of the high concentration non-avian high molecular weight hyaluronan on pain medication use among osteoarthritis patients
Abhishek S. Chitnis et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Review of the Mechanism of Action for Supartz FX in Knee Osteoarthritis
Roy D. Altman et al.
CARTILAGE (2018)
Long-term adverse effects of paracetamol - a review
J. C. McCrae et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Hyaluronic acid, an efficient biomacromolecule for treatment of inflammatory skin and joint diseases: A review of recent developments and critical appraisal of preclinical and clinical investigations
Li Hui Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis A Systematic Review and Meta-analysis
Dario Gregori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
NONOPERATIVE TREATMENTS FOR KNEE OSTEOARTHRITIS: AN EVALUATION OF TREATMENT CHARACTERISTICS AND THE INTRA- ARTICULAR PLACEBO EFFECT A Systematic Review
Christopher Vannabouathong et al.
JBJS REVIEWS (2018)
Are We Still Prescribing Opioids for Osteoarthritis?
David E. Demik et al.
JOURNAL OF ARTHROPLASTY (2017)
Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015
Gery P. Guy et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Clinical Experience With the Effectiveness and Tolerability of Hylan G-F 20 in 1047 Patients With Osteoarthritis of the Knee
David Waddell et al.
Journal of Knee Surgery (2017)
The Disease-Modifying Effects of Hyaluronan in the Osteoarthritic Disease State
Mathew A. Nicholls et al.
CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS (2017)
Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee
Roy D. Altman et al.
AMERICAN JOURNAL OF SPORTS MEDICINE (2016)
The Opioid Epidemic in the United States
Richard Gentry Wilkerson et al.
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA (2016)
Comparative safety profile of hyaluronic acid products for knee osteoarthritis: a systematic review and network meta-analysis
R. R. Bannuru et al.
OSTEOARTHRITIS AND CARTILAGE (2016)
Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis A Systematic Review and Network Meta-analysis
Raveendhara R. Bannuru et al.
ANNALS OF INTERNAL MEDICINE (2015)
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Andrew Kolodny et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 36 (2015)
The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review
R. D. Altman et al.
BMC MUSCULOSKELETAL DISORDERS (2015)
Viscosupplementation for Osteoarthritis of the Knee
David J. Hunter
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intra-articular hyaluronic acid and corticosteroids in the treatment of knee osteoarthritis: A meta-analysis
Fang Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
The Effect of Intra-articular Corticosteroids on Articular Cartilage A Systematic Review
Chloe Wernecke et al.
ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE (2015)
Are intra-articular injections of Hylan G-F 20 efficacious in painful osteoarthritis of the knee? A systematic review & meta-analysis
S. K. Pai et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
OARSI guidelines for the non-surgical management of knee osteoarthritis
T. E. McAlindon et al.
OSTEOARTHRITIS AND CARTILAGE (2014)
Lifetime Risk and Age at Diagnosis of Symptomatic Knee Osteoarthritis in the US
Elena Losina et al.
ARTHRITIS CARE & RESEARCH (2013)
Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction A Nationwide Cohort Study
Anne-Marie Schjerning Olsen et al.
CIRCULATION (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
Marc C. Hochberg et al.
ARTHRITIS CARE & RESEARCH (2012)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system
Joseph A. Boscarino et al.
ADDICTION (2010)
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
X. Chevalier et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Epidemiology of Osteoarthritis
Yuqing Zhang et al.
CLINICS IN GERIATRIC MEDICINE (2010)
Viscosupplementation with hylan G-F 20 in patients with osteoarthrosis of the knee
Jack M. Bert et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2010)
Hyaluronic Acid Viscosupplementation and Osteoarthritis: Current Uses and Future Directions
Eric J. Strauss et al.
AMERICAN JOURNAL OF SPORTS MEDICINE (2009)
Therapeutic Trajectory of Hyaluronic Acid Versus Corticosteroids in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis
Raveendhara R. Bannuru et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Functional Improvement with Hylan G-F 20 in Patients with Knee Osteoarthritis
Victoria A. Brander et al.
PHYSICIAN AND SPORTSMEDICINE (2009)
Viscosupplementation with hyaluronans for Osteoarthritis of the knee - Clinical efficacy and economic implications
David D. Waddell
DRUGS & AGING (2007)
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events
AT Chan et al.
CIRCULATION (2006)
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results
JP Raynauld et al.
OSTEOARTHRITIS AND CARTILAGE (2002)
Share Paper
